Trends in childhood cancers at Tygerberg Hospital from 1994 to 2014
Article Sidebar
Main Article Content
Abstract
Background. There is a paucity of data regarding childhood cancer incidence in low- and middle-income countries owing to a lack of
disease-specific, hospital- and population-based registries.
Objective. To describe the disease profile and outcome of children with cancer, treated at a single institution in South Africa between
1994 and 2014.
Methods. Data collected included demographic data (age at diagnosis, sex, stage or risk group, race) and 5-year overall survival (OS) of children aged ≤15 years diagnosed with cancer. Time to event and factors associated with 5-year outcomes were analysed, using Kaplan-Meier curves and Cox regression analysis.
Results. The most common malignancies were leukaemia (27.7%), brain tumours (18.4%), lymphomas (14.1%), nephroblastoma (8.0%)
and soft-tissue sarcomas (7.4%) for 935 patient records. Limited-disease solid tumours and standard-risk haematological malignancies
had good OS rates of 77.7% and 85.9%, respectively, although OS for the whole group was 60.2%. Nephroblastoma (89.3%), retinoblastoma (86.7%), Hodgkin’s lymphoma (89.7%) and Burkitt lymphoma (75.5%) had the best OS. Type of cancer (p<0.01), solid-tumour stage (p<0.001) and risk classification for haematological malignancies (p<0.001) were significantly associated with mortality.
Conclusions. Underlying cancer diagnosis, stage and risk group remained significant factors influencing survival with good OS for limited disease in solid tumours and standard-risk haematological malignancies, which was comparable with survival rates in high-income countries.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
National Center for Health Statistics. LCWK1. Deaths, Percent of Total Deaths, and Death Rates for the 15 Leading Causes of Death in 5-Year Age Groups, by Race and Sex: United States, 1999 - 2015. Atlanta: Centers for Disease Control and Prevention, 2017. https://www.cdc.gov/nchs/nvss/mortality/lcwk1.htm (accessed 19 June 2023).
Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001 - 10: A population-based registry study. Lancet Oncol 2017;18(6):719-731. https://doi.org/10.1016/S1470-2045(17)30186-9
Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Schüz J, Roman E. Childhood cancer: Estimating regional and global incidence. Cancer Epidemiol 2021;71(PB):101662. https://doi.org/10.1016/j.canep.2019.101662
Stefan DC, Stones DK. The South African Paediatric Tumour Registry – 25 years of activity. S Afr Med J 2012;102(7):605-606. https://doi.org/10.7196/samj.5719
Steliarova-Foucher E, Fidler MM, Colombet M, et al. Changing geographical
patterns and trends in cancer incidence in children and adolescents in Europe, 1991 - 2010 (Automated Childhood Cancer Information System): A population-based study. Lancet Oncol 2018;19(9):1159-1169. https://doi. org/10.1016/S1470-2045(18)30423-6
Stones DK, De Bruin GP, Esterhuizen TM, Stefan DC. Childhood cancer survival rates in two South African units. S Afr Med J 2014;104(7):501-504. https://doi. org/10.7196/samj.7882
Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999 - 2007: Results of EUROCARE-5 – a population-based study. Lancet Oncol 2014;15(1):35-47. https://doi.org/10.1016/S1470-2045(13)70548-5
Spector LG, Pankratz N, Marcotte EL, Fellow P. Genetic and nongenetic risk factors for childhood cancer. Pediatr Clin North Am 2015;62(1):11-25. https:// doi.org/10.1016/j.pcl.2014.09.013
Stiller CA. Epidemiology and genetics of childhood cancer. Oncogene 2004;23(38):6429-6444. https://doi.org/10.1038/sj.onc.1207717
Davidson A, Wainwright RD, Stones DK, et al. Malignancies in South African children with HIV. J Pediatr Hematol Oncol 2014;36(2):111-117. https://doi. org/10.1097/MPH.0b013e31829cdd49
World Health Organization. Improving childhood cancer cure rate. Geneva: WHO, 2023. https://www.who.int/activities/improving-childhood-cancer-cure- rate (accessed 24 June 2021).
Pui C, Pei D, Pappo AS, et al. Treatment outcomes in black and white children with cancer: Results from the SEER Database and St Jude Children’s Research Hospital, 1992 through 2007. J Clin Oncol 2012;30(16):2005-2012. https://doi. org/10.1200/JCO.2011.40.8617
Hesseling PB, Wessels G, van Riet FA. The Tygerberg Hospital Children’s Tumour Registry 1983 - 1993. Eur J Cancer 1995;31(9):1471-1475. https://doi. org/10.1016/0959-8049(95)00289-U
Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica 2020;105(11):2524-2539. https://doi.org/10.3324/haematol.2020.247031
Elgarten CW, Aplenc R. Pediatric acute myeloid leukemia: Updates on biology, risk stratification, and therapy. Curr Opin Pediatr 2020;32(1):57-66. https:// doi.org/10.1097/MOP.0000000000000855
Moleti ML, Al-Jadiry MF, Shateh WA, et al. Long-term results with the adapted LMB 96 protocol in children with B-cell non-Hodgkin lymphoma treated in Iraq: Comparison in two subsequent cohorts of patients. Leuk Lymphoma 2019;60(5):1224-1233. https://doi.org/10.1080/10428194.2018.1519810
Statistics South Africa. Provincial Profile: Western Cape Census 2011. Pretoria: StatsSA, 2014.
Cristina Stefan D. Patterns of distribution of childhood cancer in Africa. J Trop Pediatr 2015;61(3):165-173. https://doi.org/10.1093/tropej/fmv005
Afungchwi GM, Kruger M, Wharin PD, Bardin R, Kouya FN, Hesseling PB. The evolution of a hospital-based cancer registry in Northwest Cameroon from 2004 to 2015. J Trop Pediatr 2020;67 (3):5-14. https://doi.org/10.1093/tropej/fmaa038
Liu Z, Yang Q, Cai N, Jin L, Zhang T, Chen X. Enigmatic differences by sex in cancer incidence: Evidence from childhood cancers. Am J Epidemiol 2019;188(6):1130-1135. https://doi.org/10.1093/aje/kwz058
Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001 - 2007. Blood 2012;119(1):34-43. https://doi.org/10.1182/blood-2011-04-347872
Bakker JD, Parsons C, Rauch F. Migration and urbanization in post-apartheid South Africa. The World Bank Econ Rev 2020;34(2):509-532. https://doi. org/10.1093/wber/lhy030
Stiller CA, Parkin2 DM. International variations in the incidence of childhood renal tumours. Br J Cancer 1990;62(6):1026-1030. https://doi.org/10.1038/ bjc.1990.432
Hesseling PB, Hartley P, Zietsman L, van Lill S, Preston-Martin S, Wessels G. Incidence of acute lymphoblastic leukaemia in white and coloured children in the Western Cape. S Afr Med J 2004;94:(7):533-536. https://doi.org/10.7196/ SAMJ.2640
Erdmann F, Kielkowski D, Schonfeld SJ, et al. Childhood cancer incidence patterns by race, sex and age for 2000 - 2006: A report from the South African National Cancer Registry. Int J Cancer 2015;136(11):2628-2639. https://doi. org/10.1002/ijc.29308
Stiller CA, Bayne AM, Chakrabarty A, Kenny T, Chumas P. Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: Population-based study. BMC Cancer 2019;19(1):139. https://doi.org/10.1186/s12885-019-5344-7
Kruger M, Hendricks M, Davidson A, et al. Childhood cancer in Africa. Pediatr Blood Cancer 2014;61(4):587-592. https://doi.org/10.1002/PBC.24845 28. Pui C-H, Pei D, Pappo AS, et al. Treatment outcomes in black and white
children with cancer: Results from the SEER Database and St Jude Children’s Research Hospital, 1992 through 2007. J Clin Oncol 2012;30(16):2005-2012. https://doi.org/10.1200/JCO.2011.40.8617
Van Den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, et al. Position Paper: Rationale for the treatment of Wilms’ tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol 2017;14(12):743-752. https://doi.org/10.1038/ nrurol.2017.163
Fabian ID, Abdallah E, Abdullahi SU, et al. Global retinoblastoma presentation and analysis by national income level. JAMA Oncol 2020;6(5):685-695. https:// doi.org/10.1001/jamaoncol.2019.6716
Van Grotel M, Van Den Heuvel-Eibrink MM, Van Wering ER, et al. CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia. Pediatr Blood Cancer 2008;51(6):737-740. https://doi.org/10.1002/ pbc.21707
Afungchwi GM, Hesseling P, van Elsland SL, Kouya F, Kruger M. Destitution, treatment adherence and survival of children with Burkitt lymphoma in a twinning programme in Northwest Cameroon. Pediatr Blood Cancer 2019;66(12):1-8. https://doi.org/10.1002/pbc.27946
Viani K, Barr RD, Filho VO, Ladas EJ. Nutritional status at diagnosis among children with cancer referred to a nutritional service in Brazil. Hematol Transfus Cell Ther 2021;43(4):389-395. https://doi.org/10.1016/J.HTCT.2020.04.008
Nyblade L, Stangl A, Weiss E, Ashburn K. Combating HIV stigma in health care settings: What works? J Int AIDS Soc 2009;12(1):15. https://doi. org/10.1186/1758-2652-12-15
Stones DK. Childhood cancer: Early warning signs. Continuing Med Ed 2010;28(7):314.